Exploring brain structural effects of dopaminergic antagonism and partial agonism in antipsychotic‐naïve patients with first‐episode psychosis using normative modeling
Psychiatry and Clinical Neurosciences · 2026-03 · 80 (3) · 224-232
DOI: 10.1111/pcn.70017 ↗Kurz gefasst
Fachartikel in der Zeitschrift Psychiatry and Clinical Neurosciences, online erschienen am 05.01.2026. Verfasst von Anna Feveile und 10 weiteren Autor:innen. Beteiligte Einrichtung: Center for Neuropsychiatric Schizophrenia Research (CNSR), Mental Health Center, Glostrup, Copenhagen University Hospital - Mental Health Services CP…. Hauptthemen laut MEDLINE: Aripiprazole, Amisulpride, Antipsychotic Agents, Psychotic Disorders. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 67 Literaturangaben. Gefördert von: Lundbeck Foundation, Research Fund of the Mental Health Services - Capital Region of Denmark, Wørzner's foundation.
Abstract (Originalsprache)
Aim
Schizophrenia is associated with subtle brain structural alterations, but separating disease from medication effects is challenging. Antipsychotic dopamine D2 receptor (D2R) antagonism has been associated with striatal volume increases, but effects of partial D2R agonism by newer antipsychotics are largely unexplored. This study aimed to compare short‐term brain changes associated with either D2R antagonism or partial D2R agonism using normative modeling. Secondarily, the study aimed to explore long‐term effects following naturalistic treatment.
Methods
Antipsychotic‐naïve patients with first‐episode psychosis received 6 weeks of monotherapy with either amisulpride (D2R antagonist) ( N = 41) or aripiprazole (partial D2R agonist) ( N = 45). All patients underwent structural magnetic resonance imaging before and after 6 weeks of treatment. A subset was re‐scanned at 6 months, 1 year, and 2 years of naturalistic treatment. A pretrained normative model was applied to 186 subcortical and cortical regions. We used Wilcoxon signed‐rank tests to identify longitudinal structural deviations.
Results
Amisulpride and aripiprazole were associated with striatal volume increases after 6 weeks. No cortical effects were observed with amisulpride. Thinning of the temporal lobe was observed with aripiprazole. After 6 months, and 1 and 2 years, the striatal changes abated but cortical thinning in the frontal lobes emerged.
Conclusions
Both partial D2R agonism and D2R antagonism appear linked to striatal volume increases; however, changes appear transient. Conversely, frontal thinning occurs over time and appears less closely linked to antipsychotic treatment. Interpreting structural brain changes in patients with psychosis require consideration of short‐term pharmacological effects as well as factors related to illness progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Neuropsychiatric Schizophrenia Research (CNSR), Mental Health Center, Glostrup, Copenhagen University Hospital - Mental Health Services CPH, Copenhagen, Denmark.
- Faculty of Medicine, Tbilisi State Medical University, Tbilisi, Georgia.
- Functional Imaging Unit, Department of Clinical Physiology, Nuclear Medicine and PET, Rigshospitalet, Glostrup, Denmark.
- Mental Health Centre Glostrup, Copenhagen University Hospital - Mental Health Services CPH, Copenhagen, Denmark.
- Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
- Donders Institute for Brain, Cognition, and Behaviour, Radboud University Medical Centre, Nijmegen, Netherlands.
ORCID-Profile: Anna Feveile, Kirsten B Bojesen
Förderung
- Lundbeck Foundation
- Research Fund of the Mental Health Services - Capital Region of Denmark
- Wørzner's foundation
- The M.D. Gerhard Linds Grant, Denmark
- Wellcome Trust
- European Research Council
Zitieren
APA
Feveile, A., Ambrosen, K. S., Shalikashvili, K., Raghava, J. M., Nielsen, M. Ø., Bojesen, K. B., Bučková, B. R., Marquand, A. F., Glenthøj, B. Y., Syeda, W. T., & Ebdrup, B. H. (2026). Exploring brain structural effects of dopaminergic antagonism and partial agonism in antipsychotic‐naïve patients with first‐episode psychosis using normative modeling. Psychiatry and Clinical Neurosciences, 80(3), 224-232. https://doi.org/10.1111/pcn.70017
Vancouver
Feveile A, Ambrosen KS, Shalikashvili K, Raghava JM, Nielsen MØ, Bojesen KB, et al. Exploring brain structural effects of dopaminergic antagonism and partial agonism in antipsychotic‐naïve patients with first‐episode psychosis using normative modeling. Psychiatry and Clinical Neurosciences. 2026;80(3):224-232. doi:10.1111/pcn.70017
BibTeX
@article{Feveile2026,
author = {Feveile, Anna and Ambrosen, Karen S and Shalikashvili, Ketevan and Raghava, Jayachandra M and Nielsen, Mette Ø and Bojesen, Kirsten B and Bučková, Barbora R and Marquand, Andre F and Glenthøj, Birte Y and Syeda, Warda T and Ebdrup, Bjørn H},
title = {Exploring brain structural effects of dopaminergic antagonism and partial agonism in antipsychotic‐naïve patients with first‐episode psychosis using normative modeling},
journal = {Psychiatry and Clinical Neurosciences},
year = {2026},
volume = {80},
number = {3},
pages = {224--232},
doi = {10.1111/pcn.70017}
}
EUVIMED